Most private label sheet mask launches slip for the same three reasons: the sheet material is chosen too late, the fill volume is never checked during sampling, and compliance documentation does not start until production is already running. This playbook maps a realistic 90-day path from concept to shelf for a copper peptide sheet mask — a 30 mL, GHK-Cu-positioned facial mask concept of the kind LANTHOME develops under its private label and OEM/ODM program — and shows which decisions must be locked before sampling so the plan survives contact with reality. Every milestone below has an explicit exit condition, and every commercial term (MOQ, pricing, production schedule, availability) is the kind of item that gets confirmed in writing per project, because assumptions in the sampling phase become rework in the production phase.
A cream launches like a cream: one formula, one container, one label. A sheet mask is actually three products in one — the essence (a formula), the sheet (a textile or fiber structure), and the outer pouch or bottle (a flexible package with a seal). Any one of the three can stall a launch if it is decided late, and the interactions between them are where schedules go to die. A denser sheet absorbs more essence, which changes the fill weight you need; a change in pouch material changes the seal specification, which changes the QC check.
The copper peptide angle adds a layer of care on the claims side. GHK-Cu and related copper peptides are commonly used in skincare as active ingredients, and the Cosmetic Ingredient Review (CIR) has published safety assessments covering peptide ingredients and their metal salts as used in cosmetics. That body of review is exactly what you want on your side during the formula-review milestone: it lets you position the mask around a specific, documented active rather than a vague "peptide glow" story. Write claims as "designed to support" or "commonly used for" language, and keep every efficacy statement defensible from the final ingredient list and testing documentation your project confirms in writing.
The reference product throughout this playbook is the 30 mL private label copper peptide sheet mask, a customizable facial sheet-mask concept with reference model FAI-001518A, positioned on copper peptide / GHK-Cu, and developed with LANTHOME OEM/ODM support. Its stated customization scope — formula direction, sheet material, fragrance, packaging artwork, print finish, and carton or set configuration — is the decision list for the first two milestones of this plan, which is why it is a good teaching vehicle for a 90-day launch.
The table below is the plan. The manufacturer-side durations (sampling turnaround, production run length) are project-specific and are confirmed in writing after quotation, so treat the day windows as your internal planning framework: they sequence your own workstream in parallel with the manufacturer's, which is the only way 90 days works.
| Phase | Window | Exit condition |
|---|---|---|
| Concept, positioning, supplier shortlisting | Days 0–14 | Signed one-page spec: active story, 30 mL fill, sheet format, channel, markets |
| Sampling, formula review, sheet selection | Days 14–35 | Approved pre-production sample + written confirmation of MOQ, pricing, production schedule |
| Revisions, artwork, compliance docs | Days 35–50 | Approved dieline and label file + regulatory document checklist in progress |
| Production, QC, fill-weight verification | Days 50–70 | Finished batch with COA and batch code |
| Logistics, retail readiness | Days 70–85 | Stock allocated to first-wave channels, listing live in staging |
| Launch and measurement | Days 85–90 | Product on shelf or in cart, sell-through and return KPIs tracked |
The first two weeks are pure definition. Every week spent clarifying here buys back days later, because sheet mask decisions cascade: the active story drives the formula, the formula drives the sheet and fill weight, and both drive the label.
Step 1: Lock the active story. The reference concept is positioned on copper peptide / GHK-Cu. Decide how strong the active story is: is the copper peptide the hero on the front of the pouch, or one ingredient in a broader "peptide + hydration" narrative? The answer changes the label layout, the PDP copy and the claim language you can use. Whatever the scope, draft the claim set now, in conservative terms — "designed to support," "commonly used for" — so the artwork team builds on approved words, not hopeful ones.
Step 2: Lock the fill volume and mask form. The reference profile is a 30 mL sheet mask. Fill volume is not a cosmetic detail: it sets essence quantity per dose, drives cost per unit, and must be verifiable at QC. If your channel sells single-use masks, 30 mL is a solid middle ground; if you plan a set configuration, the per-mask volume and the carton contents are decisions that interact, so lock both.
Step 3: Lock the sheet format direction. Sheet material (fiber type, thickness, drape, face-cut style) is listed among the reviewable customization options on the reference product. You do not need the final material on day 14, but you need the direction — lightweight cotton-style drape versus hydrogel-style fit — because it affects absorption, essence load and the photography you will commission later.
Step 4: Shortlist suppliers who confirm terms in writing. The practical shortlisting question for a sheet mask program is not "who can make masks" but "who will put the final ingredient list, testing, regulatory documents, MOQ, pricing, production schedule and availability in writing after project review." That is exactly the confirmation workflow described on the reference product page, and it is what keeps days 14–70 honest. Our product development process page is a good reference for how LANTHOME structures OEM/ODM project reviews end to end.
Selection decisions at a glance:
| Decision | Reference profile | Why it locks early |
|---|---|---|
| Active story | Copper peptide / GHK-Cu positioning | Claim language, label hero, PDP copy |
| Fill volume | 30 mL reference fill | Cost per unit, dose, QC fill-weight check |
| Mask form | Sheet, facial | Sheet material direction, face-cut, photography |
| Customization scope | Formula, sheet, fragrance, artwork, print, carton/set | The sampling order is built from this list |
| Channel & markets | Defined by the brand | Drives which regulatory documents you need |
By day 14 you should hold one document — the one-page spec — plus a shortlist of two or three suppliers who have acknowledged it in writing. If you want to see where this product sits inside a broader line, the Face Care collection is the natural reference point for how a mask launch can be sequenced around existing serum and cream SKUs.
Order the full sample set in one request. The reference customization scope gives you five dials: formula direction, sheet material, fragrance, packaging artwork and print finish. Sampling one dial at a time is the classic schedule killer. Request one consolidated sample round that covers your two leading formula directions, your two leading sheet materials, and your fragrance direction, all against the one-page spec. One numbered feedback round then replaces five.
Evaluate the sheet mask against a fixed rubric. First impressions on a mask are misleading; the sheet has to perform over a full 15–20 minute wear. Score each sample on:
Write the result as a numbered revision list, one item per problem, each with the acceptance criterion ("fill weight within tolerance of 30 mL on 10 of 10 sampled units"). Vague feedback ("not quite premium") gets vague revisions.
Run the formula review in the same window. The reference product's project workflow confirms the final ingredient list only after project review and written quotation — so use days 14–35 to walk that list actively. For a copper peptide mask, the practical questions are: what peptide form is in the formula (free copper peptide versus derivative), at what concentration the program is positioned, and which supporting ingredients carry the hydration story. The CIR's published safety assessments of peptide ingredients, including the assessment of peptides and related ingredients, are a useful reference frame for the questions you put to your formula reviewer, and they keep your marketing claim set within what is documented.
Get the commercial terms in writing before day 35. MOQ for the first production run, pricing at your target order quantity, the production schedule for a fully confirmed spec, and availability — all in writing, tied to the exact sample you approved. The reference product page is explicit that these items are confirmed only after project review and written quotation, and a 90-day plan has no room for a second quotation round in week 10.
Exit condition at day 35: an approved pre-production sample with a completed rubric, a signed numbered revision list (which may be short — "no revisions" is a valid exit), and written confirmation of MOQ, pricing and production schedule.
This milestone runs two tracks in parallel: the product track (applying your revisions) and the paperwork track (artwork and regulatory documents). The paperwork track is where unprepared brands lose the most schedule, because each item has its own review loop.
Track 1 — Revisions. Apply the numbered revision list to the formula, sheet or fragrance as agreed. If any revision changes the ingredient list, the compliance track restarts for that item — which is another reason the formula review in days 14–35 matters. Keep a written record of the revised specification; it becomes the basis of the production order.
Track 2 — Artwork and print. The reference product lists packaging artwork and print finish as reviewable customization options. For a mask, the artwork package includes the pouch face file, the back-of-pouch label (ingredients, directions, responsible party, batch code zone), and — if you are launching a carton or set configuration — the carton dieline. Two practical rules: first, build the label file from your approved claim set, not from the draft; second, confirm the print finish (matte, soft-touch, foil) on a proof before you approve the file, because a finish that looks right on screen can fail on the actual pouch substrate. If you plan to launch the mask as part of a set, the carton and set configuration decision belongs in this window, not after the pouch is printed.
Track 3 — Regulatory documents. Sheet masks are cosmetics in the major markets, and the document set differs by destination. For the EU, Regulation (EC) No 1223/2009 is the governing cosmetics framework: the product file, safety assessment and responsible person requirements all key off the final ingredient list, which is why the formula must be frozen before this track closes. For the US, the FDA's cosmetics portal is the correct starting point for labeling, GMP and facility registration expectations. Manufacturing practice in both markets is benchmarked against Good Manufacturing Principles along the lines of ISO 22716, the GMP guidelines for cosmetics referenced in the EU, so asking your manufacturer how its production, control, storage and shipment practices align with that framework is a normal, documented part of due diligence.
The reference product's workflow names exactly what you are chasing in this track: the final ingredient list, testing, and regulatory documents, each confirmed for the project in writing. By day 50 the list should be in motion for every market you plan to sell into, with owners and due dates named.
Exit condition at day 50: production-ready specification (revisions applied), approved pouch and carton artwork files with print finish confirmed, and a per-market regulatory document checklist that is started and owned — with the ingredient list frozen.
With the spec, artwork and documents aligned, production can run — and the QC plan should exist before the first batch starts, not after.
The in-process checks that matter for a mask. A sheet mask batch has three failure modes worth specific checks: fill consistency (essence quantity per unit versus your 30 mL target — sample across the batch, not just at the start), sheet integrity (tears, mis-cuts, face-cut misalignment), and seal integrity (pouch welds holding under a squeeze and under transport). Each maps to a simple sampling plan: units pulled at start, middle and end of the run, with written acceptance limits agreed in the production order.
Batch documentation. Per batch you should hold the COA (certificate of analysis), the batch code printed on the units and the production record. These are the documents a retailer, distributor or marketplace will eventually ask for, and they are the evidence base for any "quality" statement you make about the program. For a copper peptide mask, the COA is also where your active ingredient story becomes verifiable: if the front of the pouch says GHK-Cu, the documentation behind it should let a buyer trace that statement to the formula and the testing.
Production schedule discipline. The reference product confirms the production schedule in writing after project review. That written schedule is your plan's backbone for the final 30 days: the logistics window, the listing go-live date and the launch marketing all hang off it. If the schedule moves in week 8, the launch date moves with it — re-baseline in writing rather than quietly absorbing the slip, because the downstream dates are commitments you have already made to your channels.
Exit condition at day 70: a finished batch with COA and batch code, in-process QC records against your sampling plan, and a confirmed shipping date.
Production done is not launch done. The final three working weeks convert a batch into a sellable, shippable, market-ready product.
Logistics. Confirm the shipping mode against your launch date and margin: sea freight for cost efficiency when the schedule allows, air for the first wave when timing is the constraint. The decision is driven by the production schedule you hold in writing — one of the items the reference program confirms per project — so make the mode decision the day the batch is cleared, not a week before departure. Check unit carton dimensions against your channel's packaging requirements (marketplace poly-bag rules, retail carton drops, distributor pallets) before the pallet is built.
Stock allocation. Allocate the first-wave stock deliberately: which channel gets first refusal, how much is held for a second wave or for set configurations, and what quantity is reserved for returns and damage. A mask is a low-unit-price, high-velocity product; under-allocation to one channel usually means a silent stockout before your first full sell-through report.
Retail readiness. The listing must exist in staging before the product ships, not after it lands. That includes the PDP copy (built from your approved claim set — "designed to support" language, not the draft's hopeful superlatives), photography (sheet, essence, pouch, in-use), the ingredient story for copper peptide / GHK-Cu, and the label images required by your marketplace. If you are launching into retail rather than e-commerce, add the shelf talker and the two-sentence briefing for the sales team: what the mask is, what the 30 mL fill means for the consumer, and which claims are approved.
Documentation pack. Assemble the buyer-facing pack in this window: COA, batch records, the final ingredient list, and the regulatory documents completed per market. Distributors and retailers increasingly request this pack at onboarding, and having it ready converts the conversation from "send us paperwork" to "let's do the first order."
Exit condition at day 85: product in transit or in the receiving warehouse, listing live in staging, stock allocated, and the documentation pack assembled and sent.
The final five days are about controlled rollout and measurement, not about doing more.
Soft launch first. Release to one channel or one test group (a small retail account, a marketplace listing with limited stock, a newsletter audience) before the full rollout. The soft launch validates three things the production phase cannot: real-world unboxing experience (seal integrity, sheet presentation, essence amount as perceived by the consumer), listing conversion, and whether the approved claim set resonates or reads as flat.
Set the KPIs before the full rollout. For a first mask launch the useful set is small: sell-through rate by week, return rate and return reasons (mask returns usually carry a specific signal — fit, dryness, fragrance), and repeat purchase at 30 days. Write the target numbers down before the rollout so the post-launch review is a comparison, not a story.
Open the feedback loop. Customer returns, reviews and retailer feedback feed directly into the wave-two spec: a fragrance note that comes back repeatedly is a formula revision; a "sheet feels thin" comment is a sheet material decision; a strong set-attach rate is an argument for the carton and set configuration option the reference product already supports. The launch is the end of the 90-day plan and the beginning of the product iteration cycle. For brands building a broader routine around the mask, the Face Care line shows how a hero mask can anchor a sequenced range.
Exit condition at day 90: product on shelf or in cart across first-wave channels, KPIs being tracked against written targets, and a wave-two feedback log started.
Reviewing where 90-day mask launches actually break, four patterns account for most of the delay:
Each of these maps to a milestone exit condition above. The fix is the same in every case: make the exit condition explicit and written, instead of assuming the next phase is "close enough."
With a milestone plan and a manufacturer that confirms terms in writing, 90 days is a workable framework for a first launch: the concept and sampling milestones compress cleanly when the spec is locked early, and production and logistics run on the written schedule. Fully custom from day one — new artwork, new carton, formula revisions mid-sampling — adds a revision round, so budget more than the base plan. Manufacturer-side durations are project-specific and confirmed in writing after quotation, which is why this plan sequences your own workstream in parallel rather than assuming a fixed factory calendar.
The reference product lists the customization scope explicitly: formula direction, sheet material, fragrance, packaging artwork, print finish, and carton or set configuration, all reviewable against your market and sales channel. That list is effectively your decision checklist for days 0–35 — lock each dial once, in one consolidated sampling round, and the rest of the plan runs on the approved spec.
The product's project workflow confirms the final ingredient list, testing and regulatory documents after project review and written quotation, per market. In practice that means the EU track runs under Regulation (EC) No 1223/2009 (product file, safety assessment, responsible person), the US track aligns with FDA cosmetics expectations for labeling and GMP, and manufacturing is benchmarked against GMP guidelines along the lines of ISO 22716. Freeze the formula before the document track closes, and the two stay in sync.
Copper peptides and related peptide ingredients are commonly used in skincare, and the Cosmetic Ingredient Review has published safety assessments covering peptide ingredients and their metal salts as used in cosmetics. That documentation is what lets you write a defensible active-ingredient story on the pouch and the PDP — keep claims in "designed to support" / "commonly used for" language and tie every statement to the final confirmed ingredient list.
A single-SKU first wave is the timeline-safe choice: fewer moving parts, faster stock allocation, cleaner KPI read. Set configuration (carton contents, multi-mask bundles) is a listed customization option on the reference product and is usually the strongest wave-two lever, because set attach tends to follow once the single mask proves sell-through. Launch the single mask, measure, then add the set with the wave-two production order.
About the Author
This article was prepared by the Lanthome skincare manufacturing team, with experience in private label formulation, packaging development, quality control, and international OEM/ODM projects.
